Concepedia

Luc Truyen

LT

11

Publications

812

Citations

11

H-Index

1989

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Vrije Universiteit Amsterdam

Amsterdam UMC Location Vrije Universiteit Amsterdam

Janssen (Belgium)

Luc Truyen is an author at Johnson & Johnson (United States) specializing in medicine, neurology, and neuroscience.

Top concepts

Publications per year

1989–2005

11

Publications

11

A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer???s Disease

Gordon Wilcock, Ian Howe, Hilary Coles et al. · Drugs & Aging · 2003 · 212 citations

, , +13

The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months

Murray A. Raskind, Elaine R. Peskind, Luc Truyen et al. · Archives of Neurology · 2004 · 165 citations

Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease

Henry Brodaty, Jody Corey‐Bloom, Felix Potocnik et al. · Dementia and Geriatric Cognitive Disorders · 2005 · 119 citations

Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study

Rutger Goekoop, Serge A.R.B. Rombouts, Cees Jonker et al. · NeuroImage · 2004 · 108 citations

, , +10

Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis

Marianne A.A. van Walderveen, Luc Truyen, Bob W. van Oosten et al. · Archives of Neurology · 1999 · 69 citations

Rows per page

1–5 of 11